Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00229697
First received: September 28, 2005
Last updated: October 2, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)